ArticleBriefings in bioinformatics2025
MIRACN: a residual convolutional neural network for predicting cell line specific functional regulatory variants.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
In post-genome-wide association study era, interpretation of noncoding variants remains a significant challenge due to their complexity and the limited understanding of their functions. Here, we developed MIRACN, a novel residual convolutional neural network designed to predict cell line-specific functional regulatory variants. By utilizing a substantial dataset from massively parallel reporter assays (MPRAs) and employing a multitask learning strategy, MIRACN was trained across seven distinct cell lines, attaining superior performance compared to existing methods, especially in predicting cell type specificity. Comparative evaluations on an independent MPRA test dataset demonstrated that MIRACN not only outperformed in identifying regulatory variants but also provided valuable insights into their cellular context-specific regulatory mechanisms. MIRACN is capable of not only providing scores for functional variants but also pinpointing the specific cell line in which these variants display their function. This enhancement has improved the resolution of current research on the functionality of noncoding variants and has paved the way for more precise diagnostic and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.